Literature DB >> 12481256

Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells.

Mohamed A Ghafar1, Aristotelis G Anastasiadis, Min-Wei Chen, Martin Burchardt, L Eric Olsson, Hui Xie, Mitchell C Benson, Ralph Buttyan.   

Abstract

BACKGROUND: Androgen withdrawal, the standard therapeutic strategy for advanced prostate cancer, induces a rapid reduction of blood flow to prostate and prostate cancer tissues and the concomitant onset of a hypoxic environment in these tissues. To establish whether hypoxia-responsiveness (by means of the action of hypoxia inducible factor [HIF] -1alpha protein) might affect the tumorigenic or survival properties of prostate cancer cells, we studied how acute exposure of cultured human prostate cancer cells (LNCaP cell line) to hypoxia might alter their pattern of gene expression and their in vitro behavior.
METHODS: LNCaP cultures were placed in a hypoxia chamber for up to 24 hr and were compared with control (normoxic) cells for the expression of gene products by Western blotting and semiquantitative reverse transcription-polymerase chain reaction techniques.
RESULTS: Exposure of LNCaP cells to acute hypoxia activated a typical cellular hypoxia response characterized by up-regulation of HIF-1alpha and vascular endothelial growth factor protein expression. In contrast, expression of differentiation-specific proteins (prostate specific antigen and androgen receptor) or proliferative-regulatory proteins (c-myc, cyclin D1, p27) were down-regulated by hypoxia. Some of these latter changes (reduction of c-myc and cyclin D expression) were not accompanied by corresponding reduction of mRNAs and were abrogated by a proteosome inhibitor (MG132), suggesting that their loss was associated with their increased degradation rather than through transcriptional controls. The phosphorylation of Akt/protein kinase B and its downstream target, forkhead protein, was highly up-regulated by hypoxia, and cells exposed to transient periods of hypoxia became significantly less sensitive to an apoptotic stimulus (exposure to phorbol ester) when compared with normoxic cells.
CONCLUSION: This study demonstrates that even acute hypoxia has the potential to drastically alter the growth, differentiation characteristics, and apoptotic sensitivity of a prostate cancer cell. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12481256     DOI: 10.1002/pros.10162

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  29 in total

1.  Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation.

Authors:  Weiming Ouyang; Dongyun Zhang; Jingxia Li; Udit N Verma; Max Costa; Chuanshu Huang
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

Review 2.  Hypoxia-Induced Signaling Promotes Prostate Cancer Progression: Exosomes Role as Messenger of Hypoxic Response in Tumor Microenvironment.

Authors:  Gagan Deep; Gati K Panigrahi
Journal:  Crit Rev Oncog       Date:  2015

3.  Antitumor activity and downregulation of pro-angiogenic molecules in human prostate cancer cells by a novel thiazolidione compound.

Authors:  Fuminori Teraishi; Shuhong Wu; Satoshi Inoue; Lidong Zhang; John J Davis; Wei Guo; Fengqin Dong; Bingliang Fang
Journal:  Prostate       Date:  2006-03-01       Impact factor: 4.104

Review 4.  Combining prostate cancer radiotherapy with therapies targeting the androgen receptor axis.

Authors:  M Ghashghaei; M Kucharczyk; S Elakshar; T Muanza; T Niazi
Journal:  Curr Oncol       Date:  2019-10-01       Impact factor: 3.677

5.  Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.

Authors:  Elena V Fernandez; Kelie M Reece; Ariel M Ley; Sarah M Troutman; Tristan M Sissung; Douglas K Price; Cindy H Chau; William D Figg
Journal:  Mol Pharmacol       Date:  2015-03-31       Impact factor: 4.436

Review 6.  Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance.

Authors:  Shaun McKenzie; Natasha Kyprianou
Journal:  J Cell Biochem       Date:  2006-01-01       Impact factor: 4.429

7.  Hypoxia increases VEGF-A production by prostate cancer and bone marrow stromal cells and initiates paracrine activation of bone marrow endothelial cells.

Authors:  Caroline Muir; Leland W K Chung; Daniel D Carson; Mary C Farach-Carson
Journal:  Clin Exp Metastasis       Date:  2006-07-07       Impact factor: 5.150

8.  Comparison of Helzel and OxyLite systems in the measurements of tumor partial oxygen pressure (pO2).

Authors:  Bixiu Wen; Muneyasu Urano; John L Humm; Venkatraman E Seshan; Gloria C Li; C Clifton Ling
Journal:  Radiat Res       Date:  2008-01       Impact factor: 2.841

9.  Tumor-specific gene expression using the survivin promoter is further increased by hypoxia.

Authors:  L Yang; Z Cao; F Li; D E Post; E G Van Meir; H Zhong; W C Wood
Journal:  Gene Ther       Date:  2004-08       Impact factor: 5.250

10.  Chronic pulmonary disease negatively influences the prognosis of patients with advanced prostate cancer.

Authors:  Chang Wook Jeong; Ja Hyeon Ku; Cheol Kwak; Hyeon Hoe Kim; Sang Eun Lee
Journal:  World J Urol       Date:  2009-02-13       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.